Home Specialties - Our Doctors Dr Giannis Chatzimichail

We Provide American Medical Standards World Class Doctors State of the Art Facilities Prestigious Medical Services Cutting Edge Technologies Patient Centeredness

Dr Giannis Chatzimichail

Dermatology

Γεσυ registered Dermatologist, Dr. Giannis Chatzimichail started his medical journey back in 2004 at the Department of Medicine of the University of Patras. His specializations include Dermatology, Dermatopathology, Diagnostic Phlebology, Allergology and Dermatological Laser. Dr Chatzimichail recently obtained his Postgraduate training on Psoriasis at the Institute of Inflammatory Diseases of the University of Lübeck, in Germany. He is fluent in English, German and Greek.

In September 2021, he joined us at AIMIS Clinics and has ever since been a valuable asset to our team of medical specialists.

09/2021 - Present: Γεσυ registered Dermatologist at AIMIS Clinics

02/2021 - 04/2021: Specialist Dermatologist - Aphrodisiologist at the Dermatology Clinic of the University of Lübeck, Germany

09/2017 - 11/2020: Postgraduate training on Psoriasis at the Institute of Inflammatory Diseases University of Lübeck, Germany

02/2020: Obtained the title Dermatologist & Afrodisiologist

02/2017 - 02/2021: Specializing in Dermatology at the Dermatology Clinic of the University of Lübeck, Germany

03/2014 - 12/2016: Specializing in Dermatology at the Dermatological Medical office of Dr. Stephan and Brunhilde Bosch, Ludwigsburg, Germany

09/2012 - 02/2014: Specializing in Dermatology at the Leutenberg Hospital, Fachkrankenhaus für Dermatologie - Schloß Friedensburg GmbH, Germany
07/2012 - 08/2012: Visiting Doctor at the Dermatological Medical office of Dr. Johann Sperl and Christine Ziegenbein, Berlin, Germany

10/2011 - 06/2012: Learned German at the interDaf e.V. am Herder-Institut of University of Leipzig, Germany

08/2010 - 08/2011: Pre-registration Doctor, 6 months Pathology, 6 months in Surgery at the General Hospital of Amoxostos, Cyprus

10/2004 - 07/2010: Department of Medicine at the University of Patras, Greece

Chatzimichail G, Zillikens D, Thaçi D. Secukinumab-Induced Chronic Discoid Lupus Erythematosus. JAAD Case Reports 6(4): 362–64.

Chatzimichail G, Günther J, Ständer S, Thaçi D. Drug survival of secukinumab, ustekinumab, and certolizumab pegol in psoriasis. A 2-year, monocentric, retrospective study. ePoster presented at the 29th European Academy of Dermatology and Venereology 29-31st October, 2020 Virtual Congress.

Trense Y, Schlüter K, Chatzimichail G, et al. Influence of the IL-17A Inhibitor Secukinumab on the Expression of Anti-microbial Peptides in Lesional Skin of Psoriasis Patients. ePoster presented at the 29th European Academy of Dermatology and Venereology 29-31st October, 2020 Virtual Congress.

Chatzimichail G, Günther J, Ständer S, Thaçi D. Drug survival of secukinumab, ustekinumab, and certolizumab pegol in psoriasis. A 2-year, monocentric, retrospective study.

(ID: 1854428 DOI:10.1080/09546634.2020.1854428). Journal of Dermatological Treatment. 14.11.2020 accepted for publication. 11.01.2021 published online.